期刊文献+

龙运光教授诊治慢性ITP经验探析 被引量:1

Study on Professor Long Yunguang’s Clinical Experience in Diagnosis and Treatment of Chronic ITP
下载PDF
导出
摘要 原发免疫性血小板减少症(primary immune thrombocytopenia,ITP),既往称为特发性血小板减少性紫癜,是一种以体液免疫和细胞免疫介导的血小板过度破坏和巨核细胞成熟障碍为特征的获得性出血性疾病[1],临床以皮肤黏膜出血为主,严重者内脏出血、颅内出血而危及生命,出血风险随年龄而增加,常根据患者血小板计数的水平和患者出血倾向的缓急分为急性ITP和慢性ITP。
作者 陈涛 龙滢任 宋国林 龙运光(指导) CHEN Tao;LONG Ying-ren;SONG Guo-lin
出处 《广西中医药大学学报》 2020年第3期4-7,共4页 Journal of Guangxi University Of Chinese Medicine
基金 国家中医药管理局第六批全国老中医药专家学术经验继承工作项目(人教发〔2017〕29号) 贵阳市科技局计划(筑科合同〔2019〕-9-4-36号) 贵州省中医药管理局中医药、民族医药专项(编号:QZYYXG-2020-3)。
  • 相关文献

参考文献4

二级参考文献32

  • 1李灵辉,张喜奎.按“四气”划分西药属性的可行性初探[J].湖北中医杂志,2005,27(1):5-7. 被引量:7
  • 2ProvanD, StasiR, NewlandAC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia[J]. Blood,2010,115(2):168-186.
  • 3NeunertC, LimW, CrowtherM, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia[J]. Blood,2011,117(16):4190-4207.
  • 4British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy[J]. Br J Haematol,2003,120(4):574-596. doi:10.1046/j.1365-2141.2003.04131.x.
  • 5WeiY, JiXB, WangYW, et al. High-dose dexamethasone versus prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial[J]. Blood,2016,127(3):296-302. doi:10.1182/blood-2015-07-659656.
  • 6WangS, YangR, ZouP, et al. A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia[J]. Int J Hematol,2012,96(2):222-228. doi:10.1007/s12185-012-1124-8.
  • 7BusselJB, ChengG, SalehMN, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura[J]. N Engl J Med,2007,357(22):2237-2247. doi:10.1056/NEJMoa073275.
  • 8BusselJB, ProvanD, ShamsiT, et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, doubleblind, placebo-controlled trial[J]. Lancet,2009,373(9664):641-648. doi:10.1016/S0140-6736(09)60402-5.
  • 9ChengG, SalehMN, MarcherC, et al. Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study[J]. Lancet,2011,377(9763):393-402. doi:10.1016/S0140-6736(10)60959-2.
  • 10SalehMN, BusselJB, ChengG, et al. Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study[J]. Blood,2013,121(3):537-545. doi:10.1182/blood-2012-04-425512.

共引文献530

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部